Product Code: MCP36197
Global Artificial Blood Vessels Market to Reach US$379.5 Million by 2030
The global market for Artificial Blood Vessels estimated at US$292.7 Million in the year 2024, is expected to reach US$379.5 Million by 2030, growing at a CAGR of 4.4% over the analysis period 2024-2030. Polydioxanone Polymer, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$177.9 Million by the end of the analysis period. Growth in the Elastomer Polymer segment is estimated at 3.0% CAGR over the analysis period.
The U.S. Market is Estimated at US$79.7 Million While China is Forecast to Grow at 8.2% CAGR
The Artificial Blood Vessels market in the U.S. is estimated at US$79.7 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$79.1 Million by the year 2030 trailing a CAGR of 8.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.8% and 3.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.6% CAGR.
Global Artificial Blood Vessels Market - Key Trends & Drivers Summarized
Are Bioengineered Vascular Grafts the Future of Cardiovascular Surgery?
The artificial blood vessels market is gaining remarkable momentum, primarily driven by the need for reliable vascular grafts in cardiovascular and peripheral artery diseases. Synthetic and bioengineered blood vessels are playing a transformative role in vascular surgeries, particularly in patients where natural vessels are unsuitable for grafting. Traditionally dominated by materials like expanded polytetrafluoroethylene (ePTFE) and Dacron, the market is now witnessing a shift toward tissue-engineered vascular grafts (TEVGs) that mimic the structure and function of native blood vessels. These newer grafts offer better biocompatibility, reduced thrombogenicity, and higher patency rates. Advances in 3D bioprinting and scaffold fabrication are pushing the boundaries of customization, enabling patient-specific grafts that improve surgical outcomes. Moreover, innovations in stem cell technology and regenerative medicine have made it possible to create grafts that integrate seamlessly with the host tissue and promote endothelialization. This is particularly beneficial in pediatric patients requiring vascular reconstructions that grow along with the child. The integration of nanotechnology and surface modifications is further enhancing the mechanical strength and anti-inflammatory properties of synthetic grafts. Additionally, research into decellularized natural vessels is opening new avenues for off-the-shelf solutions that combine the structural integrity of native tissues with the safety of sterilized grafts. The field is at the convergence of biotechnology, materials science, and clinical medicine, signaling a major leap toward the future of cardiovascular repair and reconstruction.
How Are Rising Disease Burdens and Surgical Needs Influencing Market Trajectories?
The global burden of cardiovascular diseases (CVDs), especially atherosclerosis, aneurysms, and peripheral arterial disease, is a powerful driver behind the expanding artificial blood vessels market. An aging global population, combined with increasingly sedentary lifestyles and rising rates of obesity and diabetes, is contributing to a surge in vascular complications that often necessitate surgical intervention. In many cases, patients lack suitable autologous veins or arteries for grafting, making artificial alternatives not just optional but essential. Coronary artery bypass grafting (CABG) and hemodialysis access in patients with end-stage renal disease are among the most common applications where artificial grafts are extensively used. Emerging surgical techniques, including minimally invasive vascular surgeries, are increasing the demand for flexible, durable, and highly compatible synthetic grafts. Simultaneously, healthcare systems across both developed and emerging nations are expanding their capabilities to perform complex vascular interventions, thereby increasing procedural volumes and, by extension, device utilization. Furthermore, traumatic injuries, congenital heart defects, and tumor resections involving major vessels in both military and civilian populations are creating additional use cases for artificial blood vessels. In low- and middle-income countries, improving surgical infrastructure and government investment in cardiac care are further stimulating market penetration. The need for reliable vascular conduits in emergency surgeries, coupled with greater global awareness of vascular health, is placing artificial blood vessels at the forefront of modern surgical planning.
Are Regulatory and Clinical Challenges Reshaping the Innovation Landscape?
Despite substantial technological advancement, the artificial blood vessels market remains shaped by a complex regulatory environment and significant clinical challenges. Regulatory approval processes for vascular grafts, particularly tissue-engineered and bioresorbable ones, are extremely rigorous due to the high-risk nature of cardiovascular applications. Safety, durability, biocompatibility, and long-term efficacy must be extensively demonstrated through preclinical and multi-phase clinical trials. This often extends product development timelines and increases costs, limiting the entry of smaller innovators unless they partner with established medical device companies or academic institutions. Furthermore, issues like graft rejection, infection risk, aneurysmal degeneration, and limited patency in small-diameter grafts-especially those under 6mm-continue to pose significant clinical hurdles. These challenges have fueled a wave of research aimed at developing hybrid grafts that combine synthetic scaffolds with biological components to reduce immunogenicity and enhance integration. Collaborations between biotech firms, universities, and hospitals are becoming more common as stakeholders seek to overcome translational gaps and streamline clinical validation processes. Additionally, the implementation of post-market surveillance and value-based healthcare metrics is forcing manufacturers to invest in long-term outcome studies and real-world evidence. On a global scale, market access is influenced by variable reimbursement policies, particularly in emerging economies where high graft costs can limit adoption. However, government-supported innovation ecosystems and rising private investment in medtech R&D are slowly shifting these dynamics, enabling the introduction of next-generation vascular grafts with better clinical and commercial viability.
What Key Forces Are Accelerating Global Market Growth?
The growth in the artificial blood vessels market is driven by several factors that are deeply rooted in clinical needs, technological innovation, healthcare infrastructure expansion, and shifting treatment paradigms. Foremost among these is the increasing number of cardiovascular and peripheral vascular surgeries being performed worldwide, due in large part to the growing prevalence of lifestyle-induced chronic diseases and age-related vascular degeneration. Technological progress in biomaterials, such as the development of biodegradable polymers and bioactive coatings, has enabled the creation of artificial vessels that better resist infection, thrombosis, and mechanical fatigue. Rapid advancements in 3D printing, particularly bioprinting, are making it feasible to manufacture personalized grafts tailored to individual anatomy, thus reducing complications and improving surgical success rates. The expansion of dialysis care infrastructure is another major growth driver, given the high demand for vascular access solutions among patients undergoing chronic renal replacement therapy. Additionally, a growing number of specialized cardiovascular centers, especially in emerging markets, are incorporating artificial grafts into their standard surgical toolkits. Consumer behavior is also playing a role, with patients increasingly opting for early surgical intervention and minimally invasive approaches that require high-performance grafts. End-users, including hospitals, research institutions, and surgical centers, are increasingly favoring partnerships with medical device firms to co-develop next-gen graft technologies. Furthermore, the rise of telehealth and remote monitoring tools is enabling better post-operative management, improving outcomes and reinforcing confidence in artificial graft use. Collectively, these factors are propelling the global artificial blood vessels market toward a period of sustained innovation, rising adoption, and expansive growth.
SCOPE OF STUDY:
The report analyzes the Artificial Blood Vessels market in terms of units by the following Segments, and Geographic Regions/Countries:
Segments:
Polymer (Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer, Other Polymers); Application (Aortic Disease Application, Peripheral Artery Disease Application, Hemodialysis Application)
Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
Select Competitors (Total 34 Featured) -
- Abbott Laboratories
- ArtiCasc 3D
- Artivion, Inc.
- B. Braun SE
- Becton, Dickinson and Company
- Cook Medical Incorporated
- Getinge AB
- Humacyte Inc.
- Integra LifeSciences Holdings Corp.
- Jiangsu Bioda Life Science Co., Ltd.
- Johnson & Johnson
- JOTEC GmbH
- LeMaitre Vascular Inc.
- Medtronic plc
- MicroPort Scientific Corporation
- Roumai Med
- Smith & Nephew plc
- Techshot Inc.
- Terumo Corporation
- W. L. Gore & Associates, Inc.
AI INTEGRATIONS
We're transforming market and competitive intelligence with validated expert content and AI tools.
Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.
TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.
TABLE OF CONTENTS
I. METHODOLOGY
II. EXECUTIVE SUMMARY
- 1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Tariff Impact on Global Supply Chain Patterns
- Artificial Blood Vessels - Global Key Competitors Percentage Market Share in 2025 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
- 2. FOCUS ON SELECT PLAYERS
- 3. MARKET TRENDS & DRIVERS
- Growing Demand for Vascular Grafts in Cardiovascular Surgery Throws the Spotlight on Artificial Blood Vessels
- Development of Biocompatible and Non-Thrombogenic Materials Improves Graft Longevity
- Use in Coronary, Peripheral, and Dialysis-Related Procedures Sustains Diverse Clinical Demand
- Advances in Electrospinning and Tissue Engineering Enable Scaffold-Free Vessel Fabrication
- Focus on Small-Diameter Vessels Expands Possibilities in Coronary Applications
- Increase in Endovascular and Minimally Invasive Techniques Spurs Compatibility Requirements
- Integration With Drug-Eluting and Anti-Infection Coatings Enhances Post-Operative Outcomes
- Expansion of Organ Transplant and Bypass Surgeries Drives Hospital Procurement
- Longitudinal Studies Strengthen Evidence Base and Regulatory Confidence
- Growing Interest in Personalized and 3D-Printed Vascular Grafts Supports Tailored Therapies
- Use in Pediatric and Congenital Applications Highlights Unmet Needs in Niche Segments
- 4. GLOBAL MARKET PERSPECTIVE
- TABLE 1: World Artificial Blood Vessels Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
- TABLE 2: World Recent Past, Current & Future Analysis for Artificial Blood Vessels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 3: World Historic Review for Artificial Blood Vessels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 4: World 16-Year Perspective for Artificial Blood Vessels by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
- TABLE 5: World Recent Past, Current & Future Analysis for Polydioxanone Polymer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 6: World Historic Review for Polydioxanone Polymer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 7: World 16-Year Perspective for Polydioxanone Polymer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 8: World Recent Past, Current & Future Analysis for Elastomer Polymer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 9: World Historic Review for Elastomer Polymer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 10: World 16-Year Perspective for Elastomer Polymer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 11: World Recent Past, Current & Future Analysis for Polyethylene Terephthalate Polymer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 12: World Historic Review for Polyethylene Terephthalate Polymer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 13: World 16-Year Perspective for Polyethylene Terephthalate Polymer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 14: World Recent Past, Current & Future Analysis for Other Polymers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 15: World Historic Review for Other Polymers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 16: World 16-Year Perspective for Other Polymers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 17: World Recent Past, Current & Future Analysis for Aortic Disease Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 18: World Historic Review for Aortic Disease Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 19: World 16-Year Perspective for Aortic Disease Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 20: World Recent Past, Current & Future Analysis for Peripheral Artery Disease Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 21: World Historic Review for Peripheral Artery Disease Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 22: World 16-Year Perspective for Peripheral Artery Disease Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 23: World Recent Past, Current & Future Analysis for Hemodialysis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 24: World Historic Review for Hemodialysis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 25: World 16-Year Perspective for Hemodialysis Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
III. MARKET ANALYSIS
- UNITED STATES
- Artificial Blood Vessels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
- TABLE 26: USA Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 27: USA Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 28: USA 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
- TABLE 29: USA Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 30: USA Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 31: USA 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
- CANADA
- TABLE 32: Canada Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 33: Canada Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 34: Canada 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
- TABLE 35: Canada Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 36: Canada Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 37: Canada 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
- JAPAN
- Artificial Blood Vessels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
- TABLE 38: Japan Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 39: Japan Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 40: Japan 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
- TABLE 41: Japan Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 42: Japan Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 43: Japan 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
- CHINA
- Artificial Blood Vessels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
- TABLE 44: China Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 45: China Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 46: China 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
- TABLE 47: China Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 48: China Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 49: China 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
- EUROPE
- Artificial Blood Vessels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
- TABLE 50: Europe Recent Past, Current & Future Analysis for Artificial Blood Vessels by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 51: Europe Historic Review for Artificial Blood Vessels by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 52: Europe 16-Year Perspective for Artificial Blood Vessels by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
- TABLE 53: Europe Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 54: Europe Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 55: Europe 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
- TABLE 56: Europe Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 57: Europe Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 58: Europe 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
- FRANCE
- Artificial Blood Vessels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
- TABLE 59: France Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 60: France Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 61: France 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
- TABLE 62: France Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 63: France Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 64: France 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
- GERMANY
- Artificial Blood Vessels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
- TABLE 65: Germany Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 66: Germany Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 67: Germany 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
- TABLE 68: Germany Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 69: Germany Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 70: Germany 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
- ITALY
- TABLE 71: Italy Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 72: Italy Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 73: Italy 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
- TABLE 74: Italy Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 75: Italy Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 76: Italy 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
- UNITED KINGDOM
- Artificial Blood Vessels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
- TABLE 77: UK Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 78: UK Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 79: UK 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
- TABLE 80: UK Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 81: UK Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 82: UK 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
- SPAIN
- TABLE 83: Spain Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 84: Spain Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 85: Spain 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
- TABLE 86: Spain Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 87: Spain Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 88: Spain 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
- RUSSIA
- TABLE 89: Russia Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 90: Russia Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 91: Russia 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
- TABLE 92: Russia Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 93: Russia Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 94: Russia 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
- REST OF EUROPE
- TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 96: Rest of Europe Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 97: Rest of Europe 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
- TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 99: Rest of Europe Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 100: Rest of Europe 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
- ASIA-PACIFIC
- Artificial Blood Vessels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
- TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Blood Vessels by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 102: Asia-Pacific Historic Review for Artificial Blood Vessels by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 103: Asia-Pacific 16-Year Perspective for Artificial Blood Vessels by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
- TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 105: Asia-Pacific Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 106: Asia-Pacific 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
- TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 108: Asia-Pacific Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 109: Asia-Pacific 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
- AUSTRALIA
- Artificial Blood Vessels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
- TABLE 110: Australia Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 111: Australia Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 112: Australia 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
- TABLE 113: Australia Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 114: Australia Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 115: Australia 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
- INDIA
- Artificial Blood Vessels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
- TABLE 116: India Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 117: India Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 118: India 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
- TABLE 119: India Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 120: India Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 121: India 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
- SOUTH KOREA
- TABLE 122: South Korea Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 123: South Korea Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 124: South Korea 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
- TABLE 125: South Korea Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 126: South Korea Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 127: South Korea 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
- REST OF ASIA-PACIFIC
- TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 129: Rest of Asia-Pacific Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
- TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 132: Rest of Asia-Pacific Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 133: Rest of Asia-Pacific 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
- LATIN AMERICA
- Artificial Blood Vessels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
- TABLE 134: Latin America Recent Past, Current & Future Analysis for Artificial Blood Vessels by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 135: Latin America Historic Review for Artificial Blood Vessels by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 136: Latin America 16-Year Perspective for Artificial Blood Vessels by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
- TABLE 137: Latin America Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 138: Latin America Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 139: Latin America 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
- TABLE 140: Latin America Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 141: Latin America Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 142: Latin America 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
- ARGENTINA
- TABLE 143: Argentina Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 144: Argentina Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 145: Argentina 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
- TABLE 146: Argentina Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 147: Argentina Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 148: Argentina 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
- BRAZIL
- TABLE 149: Brazil Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 150: Brazil Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 151: Brazil 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
- TABLE 152: Brazil Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 153: Brazil Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 154: Brazil 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
- MEXICO
- TABLE 155: Mexico Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 156: Mexico Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 157: Mexico 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
- TABLE 158: Mexico Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 159: Mexico Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 160: Mexico 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
- REST OF LATIN AMERICA
- TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 162: Rest of Latin America Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 163: Rest of Latin America 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
- TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 165: Rest of Latin America Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 166: Rest of Latin America 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
- MIDDLE EAST
- Artificial Blood Vessels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
- TABLE 167: Middle East Recent Past, Current & Future Analysis for Artificial Blood Vessels by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 168: Middle East Historic Review for Artificial Blood Vessels by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 169: Middle East 16-Year Perspective for Artificial Blood Vessels by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
- TABLE 170: Middle East Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 171: Middle East Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 172: Middle East 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
- TABLE 173: Middle East Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 174: Middle East Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 175: Middle East 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
- IRAN
- TABLE 176: Iran Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 177: Iran Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 178: Iran 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
- TABLE 179: Iran Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 180: Iran Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 181: Iran 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
- ISRAEL
- TABLE 182: Israel Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 183: Israel Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 184: Israel 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
- TABLE 185: Israel Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 186: Israel Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 187: Israel 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
- SAUDI ARABIA
- TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 189: Saudi Arabia Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 190: Saudi Arabia 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
- TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 192: Saudi Arabia Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 193: Saudi Arabia 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
- UNITED ARAB EMIRATES
- TABLE 194: UAE Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 195: UAE Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 196: UAE 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
- TABLE 197: UAE Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 198: UAE Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 199: UAE 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
- REST OF MIDDLE EAST
- TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 201: Rest of Middle East Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 202: Rest of Middle East 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
- TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 204: Rest of Middle East Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 205: Rest of Middle East 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
- AFRICA
- Artificial Blood Vessels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
- TABLE 206: Africa Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 207: Africa Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 208: Africa 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
- TABLE 209: Africa Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 210: Africa Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 211: Africa 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
IV. COMPETITION